BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17341539)

  • 1. Bupropion therapy for pathological gambling.
    Padala PR; Madaan V; Sattar SP
    Ann Pharmacother; 2007 Mar; 41(3):529. PubMed ID: 17341539
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of bupropion for smoking cessation in rural New South Wales.
    Wong BS; Fraser J
    Aust J Rural Health; 2004 Apr; 12(2):38-9. PubMed ID: 15023219
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychopharmacology of smoking cessation in patients with mental illness.
    Selby P
    J Psychiatry Neurosci; 2006 Sep; 31(5):360. PubMed ID: 16951737
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute psychosis after administration of bupropion hydrochloride (Zyban)].
    Neumann M; Livak V; Paul HW
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S140-1. PubMed ID: 15570532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wellbutrin versus generic bupropion.
    Med Lett Drugs Ther; 2008 Jul; 50(1290):54-5. PubMed ID: 18617874
    [No Abstract]   [Full Text] [Related]  

  • 6. The "bupropion for smoking cessation" trial from a family practice perspective.
    Caplan BJ
    Arch Intern Med; 2005 Feb; 165(4):470. PubMed ID: 15738382
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
    Simon JA; Duncan C; Huggins J; Solkowitz S; Carmody TP
    Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study.
    Black DW; Arndt S; Coryell WH; Argo T; Forbush KT; Shaw MC; Perry P; Allen J
    J Clin Psychopharmacol; 2007 Apr; 27(2):143-50. PubMed ID: 17414236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in bupropion findings is not due to differences in measurement: comment on Teneggi et al.
    Shiffman S
    Psychopharmacology (Berl); 2006 Apr; 185(3):400-1. PubMed ID: 16482480
    [No Abstract]   [Full Text] [Related]  

  • 10. Bupropion for depression in schizophrenia: a case report.
    Englisch S; Esser A; Zink M
    Pharmacopsychiatry; 2010 Jan; 43(1):38-9. PubMed ID: 20178095
    [No Abstract]   [Full Text] [Related]  

  • 11. Buproprion, public funding, and smoking cessation.
    Bloomfield A
    N Z Med J; 2005 Jul; 118(1218):U1576. PubMed ID: 16027759
    [No Abstract]   [Full Text] [Related]  

  • 12. Once-daily bupropion associated with improved patient adherence compared with twice-daily bupropion in treatment of depression.
    McLaughlin T; Hogue SL; Stang PE
    Am J Ther; 2007; 14(2):221-5. PubMed ID: 17414593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful treatment of depression in a Parkinson disease patient with bupropion].
    Leentjens AF; Verhey FR; Vreeling FW
    Ned Tijdschr Geneeskd; 2000 Nov; 144(45):2157-9. PubMed ID: 11086491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupropion and cognitive-behavioral therapy for smoking cessation in women.
    Schmitz JM; Stotts AL; Mooney ME; Delaune KA; Moeller GF
    Nicotine Tob Res; 2007 Jun; 9(6):699-709. PubMed ID: 17558827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective noradrenaline-dopamine reuptake inhibition (SNDRI). More latitude for antidepressive therapy].
    MMW Fortschr Med; 2007 May; 149 Suppl 2():88-9. PubMed ID: 17724976
    [No Abstract]   [Full Text] [Related]  

  • 16. Delirium associated with concomitant use of low-dose bupropion sustained release and fluoxetine.
    Chan CH; Liu HC; Huang MC
    J Clin Psychopharmacol; 2006 Dec; 26(6):677-9. PubMed ID: 17110836
    [No Abstract]   [Full Text] [Related]  

  • 17. PHARMAC and tobacco control in New Zealand: government policy 'up in smoke'.
    Holt S; Harwood M; Aldington S; Beasley R
    N Z Med J; 2005 Jun; 118(1216):U1502. PubMed ID: 15937536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine positive toxicology screen secondary to bupropion.
    Weintraub D; Linder MW
    Depress Anxiety; 2000; 12(1):53-4. PubMed ID: 10999247
    [No Abstract]   [Full Text] [Related]  

  • 19. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupropion XL for the sustained treatment of trichotillomania.
    Klipstein KG; Berman L
    J Clin Psychopharmacol; 2012 Apr; 32(2):298-9. PubMed ID: 22388165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.